These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17900834)
1. Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors. Chen S; Liu M; Jin S; Wang B Int J Pharm; 2008 Feb; 349(1-2):180-7. PubMed ID: 17900834 [TBL] [Abstract][Full Text] [Related]
2. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Xu Y; Zhan C; Fan L; Wang L; Zheng H Int J Pharm; 2007 May; 336(2):329-37. PubMed ID: 17223290 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies. Alsarra IA Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815 [TBL] [Abstract][Full Text] [Related]
4. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery. Pawar H; Douroumis D; Boateng JS Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac. Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557 [TBL] [Abstract][Full Text] [Related]
6. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Pasparakis G; Bouropoulos N Int J Pharm; 2006 Oct; 323(1-2):34-42. PubMed ID: 16828245 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions. Jin S; Feng L; Yu X J Control Release; 2011 Nov; 152 Suppl 1():e39-41. PubMed ID: 22195912 [No Abstract] [Full Text] [Related]
8. Preparation and properties of modified chitosan as potential matrix materials for drug sustained-release beads. Ding P; Huang KL; Li GY; Liu YF Int J Biol Macromol; 2007 Jul; 41(2):125-31. PubMed ID: 17376525 [TBL] [Abstract][Full Text] [Related]
9. Preparation of chitosan beads by simultaneous cross-linking/insolubilisation in basic pH. Rheological optimisation and drug loading/release behaviour. Barreiro-Iglesias R; Coronilla R; Concheiro A; Alvarez-Lorenzo C Eur J Pharm Sci; 2005 Jan; 24(1):77-84. PubMed ID: 15626580 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery. Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856 [TBL] [Abstract][Full Text] [Related]
11. Effect of drying processes and curing time of chitosan-lysine semi-IPN beads on chlorpheniramine maleate delivery. Kumari K; Kundu PP J Microencapsul; 2009 Feb; 26(1):54-62. PubMed ID: 18608801 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation. Kofuji K; Akamine H; Qian CJ; Watanabe K; Togan Y; Nishimura M; Sugiyama I; Murata Y; Kawashima S Int J Pharm; 2004 Mar; 272(1-2):65-78. PubMed ID: 15019070 [TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840 [TBL] [Abstract][Full Text] [Related]
14. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles. Lin CC; Fu CH Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009 [TBL] [Abstract][Full Text] [Related]
15. The rheological behaviour and drug-delivery property of chitosan/rectorite nanocomposites. Wang X; Tang Y; Li Y; Zhu Z; Du Y J Biomater Sci Polym Ed; 2010; 21(2):171-84. PubMed ID: 20092683 [TBL] [Abstract][Full Text] [Related]
16. Chitosan microparticle preparation for controlled drug release by response surface methodology. Ko JA; Park HJ; Park YS; Hwang SJ; Park JB J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667 [TBL] [Abstract][Full Text] [Related]
17. Cross-linking of chitosan and chitosan/poly(ethylene oxide) beads: a theoretical treatment. Martinez L; Agnely F; Leclerc B; Siepmann J; Cotte M; Geiger S; Couarraze G Eur J Pharm Biopharm; 2007 Sep; 67(2):339-48. PubMed ID: 17408936 [TBL] [Abstract][Full Text] [Related]
18. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Anal AK; Stevens WF; Remuñán-López C Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452 [TBL] [Abstract][Full Text] [Related]
19. Effect of molecular weight and ionic strength on the formation of polyelectrolyte complexes based on poly(methacrylic acid) and chitosan. de Vasconcelos CL; Bezerril PM; dos Santos DE; Dantas TN; Pereira MR; Fonseca JL Biomacromolecules; 2006 Apr; 7(4):1245-52. PubMed ID: 16602745 [TBL] [Abstract][Full Text] [Related]
20. Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Park KM; Bae JW; Joung YK; Shin JW; Park KD Colloids Surf B Biointerfaces; 2008 May; 63(1):1-6. PubMed ID: 18314312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]